Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic. II. Quality-of-life findings from a randomized clinical trial: SST group H Trial: SST Report No. 10

Archives of Ophthalmology

Volumn 122, Issue 11, 2004, Pages 1616-1628

  Hawkins, Barbara S ^a  

^a SST Coordinating Center ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANXIETY DISORDER; ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; EYE SURGERY; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HEALTH SURVEY; HUMAN; IDIOPATHIC DISEASE; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MENTAL CAPACITY; OBSERVATION; OCULAR HISTOPLASMOSIS; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA LUTEA; SCORING SYSTEM; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISION; VISUAL ACUITY;

ADULT; AGED; CHOROIDAL NEOVASCULARIZATION; EYE INFECTIONS, FUNGAL; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOVEA CENTRALIS; HEALTH STATUS; HISTOPLASMOSIS; HUMANS; MALE; MIDDLE AGED; OBSERVATION; OPHTHALMOLOGIC SURGICAL PROCEDURES; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SYNDROME; VISUAL ACUITY;

EID: 8144225698     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.122.11.1616     Document Type: Article

References (25)

1. Ware JE Jr. Evaluating measures of general health concepts for use in clinical trials. In: Furberg C, Schuttinga JA, eds. Quality of Life Assessment. Practice, Problems, and Promise: Proceedings of a Workshop, October 15-17, 1990. Washington, DC: US Dept of Health and Human Services; 1993:51-63. NIH publication 93-3503.
2. Patrick DL. Reactions and recommendations: quality of life in NIH-sponsored studies. In: Furberg C, Schuttinga JA, eds. Quality of Life Assessment. Practice, Problems, and Promise. Proceedings of a Workshop, October 15-17, 1990. Washington, DC: US Dept of Health and Human Services; 1993:81-88. NIH publication 93-3503.
3. Drummond MF, Ferris FF III. Major themes and conclusions: a strategy for measurement of quality of life in National Eye Institute Trials. In: Drummond MF, ed. Measuring the Quality of Life of People With Visual Impairment: Proceedings of a Workshop. Washington, DC: US Dept of Health and Human Services; 1990:65-66. NIH publication 90-3098.
4. McDowell I. General health measurement and quality of life in visual impairment. In: Drummond MF, ed. Measuring the Quality of Life of People With Visual Impairment: Proceedings of a Workshop. Washington, DC: US Dept of Health and Human Services; 1990:29-33. NIH publication 90-3098.
5. Submacular Surgery Trials Pilot Study Investigators. Submacular Surgery Trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration, II: Quality-of-life outcomes: Submacular Surgery Trials Pilot Study report No. 2. Am J Ophthalmol. 2000;130:408-418.
6. Submacular Surgery Trials Research Group. Health- and vision-targeted quality of life among patients with ocular histoplasmosis or idiopathic choroidal neovascularization at time of enrollment in a randomized trial of submacular surgery: SST report No. 5. Arch Ophthalmol. In press.
7. Submacular Surgery Trials Research Group. Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic, I: ophthalmic findings from a randomized clinical trial: SST Group H Trial: SST report No. 9. Arch Ophthalmol. 2004;122:1597-1611.
8. Submacular Surgery Trials Research Group. Submacular Surgery Trials (SST) Manual of Procedures. Springfield, Va: National Technical Information Service; 1998. NTIS accession No. PB98-166648.
9. Submacular Surgery Trials Research Group. Submacular Surgery Trials (SST) Farms Book. Springfield, Va: National Technical Information Service; 1998. NTIS accession No. PB98-159445.
10. Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD; National Eye Institute Visual Function Questionnaire Field Test Investigators. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119:1050-1058.
11. Mangione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD; NEI-VFQ Field Test Investigators. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). Arch Ophthalmol. 1998;116:1496-1504.
12. VFQ-25 Rand Health homepage. Available at: http://www.rand.org/health/ surveys/vfq25/. Accessed September 24, 2004.
13. Ware JE, Snow KK, Kosinski M, Gaskel B. SF-36 Health Survey Manual and Interpretation Guide. Boston, Mass: The Health Institute, New England Medical Center, 1993.
14. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361-370.
15. Submacular Surgery Trials Research Group. Patients' perceptions of the value of current vision: assessment of preference values among patients with subfoveal choroidal neovascularization - The Submacular Surgery Trials Vision Preference Value Scale (SST-VPVS). SST report No. 6. Arch Ophthalmol. In press.
16. Ware JE, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston, Mass: The Health Institute, New England Medical Center; 1994.
17. Williams RA, Brody BL, Thomas RG, Kaplan RM, Brown SJ. The psychological impact of macular degeneration. Arch Ophthalmol. 1998;116:514-520.
18. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale: a review of validation data and clinical results. J Psychosom Res. 1997;42:17-41.
19. Tukey JW. Exploratory Data Analysis. Reading, Mass: Addison-Wesley Publishing Co; 1977:34-41.
20. Snedecor GW, Cochran WG. Statistical Methods. 7th ed. Ames: Iowa State University Press; 1980:144-145.
21. Submacular Surgery Trials Research Group. Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization: SST report No. 1. [published correction appears in Arch Ophthalmol. 2003;121:1513]. Arch Ophthalmol. 2003;121:531-539.
22. Submacular Surgery Trials Research Group. Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: quality-of-life findings: SST report No. 14. Ophthalmology. 2004;111:2007-2014.
23. Submacular Surgery Trials Research Group. Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: quality-of-life findings: SST report No. 12. Ophthalmology. 2004;111:1981-1992.
24. Childs AL and the Submacular Surgery Trials Patient-Centered Outcomes Subcommittee for the Submacular Surgery Trials Pilot Study Investigators. Responsiveness of the SF-36 Health Survey to changes in visual acuity among patients with subfoveal choroidal neovascularization. Am J Ophthalmol. 2004;137:373-375.
25. Miskala PH, Bressler NM, Meinert CL. Relative contributions of reduced vision and general health to NEI-VFQ scores in patients with neovascular age-related macular degeneration. Arch Ophthalmol. 2004;122:758-766.